Sector ratings GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:53 2026-07-15 EDT			5-day change	1st Jan Change
2,485.65 ^INR	+0.90%		+3.44%	+0.59%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	4.34B	-	-	-	-
ELI LILLY AND COMPANY	1,028B		A
JOHNSON & JOHNSON	611B		BBB
ABBVIE INC.	432B		AA	-
ROCHE HOLDING AG	323B		AA
NOVARTIS AG	277B		AAA
ASTRAZENECA PLC	257B		A
NOVO NORDISK A/S	217B		A
AMGEN INC.	192B		A
GILEAD SCIENCES, INC.	161B		AA
PFIZER INC.	138B		A
VERTEX PHARMACEUTICALS INCORPORATED	121B		AA
BRISTOL-MYERS SQUIBB COMPANY	116B		A
SANOFI	104B		AA
GSK PLC	103B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	73.58B		AA
BAYER AG	55.22B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	53.42B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	51.97B		AA
HALEON PLC	42.52B		AA
Average	218.05B		AA
Weighted average by Cap.			AA